Literature DB >> 18238965

Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age.

Catalina De Paco1, Nikos Kametas, Gustavo Rencoret, Isolde Strobl, Kypros H Nicolaides.   

Abstract

OBJECTIVE: To investigate maternal cardiac output in the first trimester as a predictor of preeclampsia and delivery of small for gestational age (SGA) infants.
METHODS: In women attending for routine care between 11(+0) and 13(+6) weeks of gestation, we recorded maternal variables and measured cardiac output by echocardiography. We compared cardiac output in those that developed preeclampsia (n=83), pregnancy-induced hypertension (PIH) (n=87), or SGA (n=532) with those unaffected by preeclampsia, PIH, or SGA (n=3,591). Regression analysis was used to first determine which of the factors among the maternal variables were significant predictors of cardiac output in the unaffected group and, secondly, to predict each complication by a combination of maternal variables and cardiac output.
RESULTS: In the unaffected group, cardiac output increased with gestation and maternal weight and decreased with maternal age. Cardiac output was higher in parous women, in cigarette smokers, in those taking antihypertensive or beta-mimetic medications, and in those conceiving after in vitro fertilization, and lower in women of Afro-Caribbean origin. Compared with the unaffected group, cardiac output was significantly higher in the preeclampsia and PIH groups and lower in the SGA group. In screening by cardiac output and maternal variables, for a 10% false-positive rate, the detection rates were 43.4% for all preeclampsia, 52% for preeclampsia without SGA, 23.3% for PIH, and 23.9% for SGA.
CONCLUSION: In pregnancies complicated by preeclampsia, PIH, and SGA, alterations in maternal cardiac output predate the clinical onset of the disorders by several months. Maternal cardiac output in the first trimester is increased in women who develop preeclampsia and decreased in women who deliver SGA infants. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2008        PMID: 18238965     DOI: 10.1097/01.AOG.0000298622.22494.0c

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

1.  GPCRs as potential therapeutic targets in preeclampsia.

Authors:  Jt McGuane; Kp Conrad
Journal:  Drug Discov Today Dis Models       Date:  2012-07-12

2.  Maternal Cardiovascular Dysregulation During Early Pregnancy After In Vitro Fertilization Cycles in the Absence of a Corpus Luteum.

Authors:  Kirk P Conrad; John W Petersen; Yueh-Yun Chi; Xiaoman Zhai; Minjie Li; Kuei-Hsun Chiu; Jing Liu; Melissa D Lingis; R Stan Williams; Alice Rhoton-Vlasak; Joseph J Larocca; Wilmer W Nichols; Mark S Segal
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

Review 3.  Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia.

Authors:  Omar C Logue; Eric M George; Gene L Bidwell
Journal:  Clin Sci (Lond)       Date:  2016-08-01       Impact factor: 6.124

Review 4.  Preeclampsia and eclampsia: the conceptual evolution of a syndrome.

Authors:  Offer Erez; Roberto Romero; Eunjung Jung; Piya Chaemsaithong; Mariachiara Bosco; Manaphat Suksai; Dahiana M Gallo; Francesca Gotsch
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

Review 5.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

6.  Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies.

Authors:  Kirk P Conrad; Valerie L Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-24       Impact factor: 3.619

Review 7.  G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.

Authors:  Kirk P Conrad
Journal:  Hum Reprod Update       Date:  2016-07-06       Impact factor: 15.610

Review 8.  Why non-invasive maternal hemodynamics assessment is clinically relevant in early pregnancy: a literature review.

Authors:  Sharona Vonck; Anneleen Simone Staelens; Ine Bollen; Lien Broekx; Wilfried Gyselaers
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-12       Impact factor: 3.007

9.  The role of the erythrocyte in the outcome of pregnancy with preeclampsia.

Authors:  Márcia Aires Rodrigues de Freitas; Alice Vieira da Costa; Luciana Alves Medeiros; Lucas Moreira Cunha; Ubirajara Coutinho Filho; Mario da Silva Garrote Filho; Angélica Lemos Debs Diniz; Nilson Penha-Silva
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

10.  Maternal cardiovascular hemodynamics in normotensive versus preeclamptic pregnancies: a prospective longitudinal study using a noninvasive cardiac system (NICaS™).

Authors:  Anat Lavie; Maya Ram; Shaul Lev; Yair Blecher; Uri Amikam; Yael Shulman; Tomer Avnon; Eran Weiner; Ariel Many
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-14       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.